Doctor Christina Paitazoglou
University Heart Center, Luebeck (Germany)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study
Event: ESC Congress 2023
Topic: Multidisciplinary Interventions
Session: Complex and novel interventions for heart failure
Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH
Event: Heart Failure 2023
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Heart failure with reduced ejection fraction (HFrEF) 3
Comparison 8 vs. 10mm fenestration size of the atrial flow regulator in patients with heart failure with reduced and preserved ejection fraction: an analysis of the Prelieve Trial
Event: Heart Failure 2022
Topic: Diastolic Ventricular Dysfunction
Session: Heart Failure ePosters - focus on Chronic Heart Failure 5
Feasibility of transcatheter procedures in patients with heart failure with reduced and preserved ejection fraction treated with the atrial flow regulator: a 3-D heart model
Event: Heart Failure 2022
Topic: Diastolic Ventricular Dysfunction
Session: Heart Failure ePosters - focus on Chronic Heart Failure 3
Overcoming NOAC limitations.
Event: ESC Heart & Stroke 2022
Topic: Stroke
Session: Satellite Symposia
ESC 365 is supported by
